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Pasteurella multocida is the causative agent of a number of diseases in animals, including fowl cholera.
P. multocida strains simultaneously express two lipopolysaccharide (LPS) glycoforms (glycoforms A and
B) that differ only in their inner core structure. Glycoform A contains a single 3-deoxy-D-manno-octu-
losonic acid (Kdo) residue that is phosphorylated by the Kdo kinase, KdkA, whereas glycoform B contains
two unphosphorylated Kdo residues. We have previously shown that P. multocida mutants lacking the
heptosyltransferase, HptA, produce full-length glycoform B LPS and a large amount of truncated glyco-
form A LPS, as they cannot add heptose to the glycoform A inner core. These hptA mutants were attenuated
in chickens because the truncated LPS made them vulnerable to host defense mechanisms, including
antimicrobial peptides. However, here we show that birds inoculated with high doses of the hptA mutant
developed fowl cholera and the P. multocida isolates recovered from diseased birds no longer expressed
truncated LPS. Sequencing analysis revealed that the in vivo-derived isolates had mutations in kdkA,
thereby suppressing the production of glycoform A LPS. Interestingly, a number of the spontaneous KdkA
mutant strains produced KdkA with a single amino acid substitution (A112V, R123P, H168Y, or D193N).
LPS structural analysis showed that complementation of a P. multocida kdkA mutant with wild-type kdkA
restored expression of glycoform A to wild-type levels, whereas complementation with any of the mutated
kdkA genes did not. We conclude that in P. multocida KdkA, the amino acids A112, R123, H168, and D193
are critical for Kdo kinase function and therefore for glycoform A LPS assembly.
Pasteurella multocida is a Gram-negative pathogen that is
the causative agent of a wide range of diseases in animals,
including bovine hemorrhagic septicemia, fowl cholera, and
porcine atrophic rhinitis (4). The major virulence determinants
in P. multocida include the capsule and lipopolysaccharide
(LPS), both of which vary in composition and structure be-
tween strains (2, 5, 7–8, 11, 21–23). The LPS of P. multocida is
composed of an inner and an outer core region, and like the
LPS produced by species within the Neisseria and Haemophilus
genera, P. multocida LPS lacks the polymeric O antigen that is
attached to the distal end of the LPS structure in most other
Gram-negative bacteria (6, 9, 17, 20, 23). Structural analysis of
the LPS isolated from a number of P. multocida strains re-
vealed that most simultaneously produce two LPS glycoforms
that differ only in their inner core structure (23; A. Cox, un-
published observations). The key difference between the two
structures is that the glycoform A inner core contains a single
phosphorylated 3-deoxy-D-manno-octulosonic acid (Kdo) res-
idue (lipid A-Kdo1-P), with the phosphate group frequently
being substituted with phosphoethanolamine (PEtn), whereas
the glycoform B inner core contains two Kdo residues (lipid
A-Kdo1-Kdo2) (22).
The enzymes required for assembly of the LPS inner core
have been identified and include a Kdo transferase, KdtA,
that is predicted to add both the first and the second (gly-
coform B only) Kdo residues; a Kdo kinase, KdkA, that adds
the phosphate group to the lipid A-Kdo1 for assembly of
glycoform A; and two heptosyltransferases, HptA and HptB,
specific for the addition of the first heptose to glycoform A
and glycoform B, respectively (Fig. 1) (10). Previous data
suggest that the amount of each glycoform produced is pri-
marily dependent upon the phosphorylation activity of the
glycoform A-specific Kdo kinase: if the lipid A-Kdo1 accep-
tor molecule is phosphorylated by KdkA, the molecule is
recognized by HptA and glycoform A is assembled, whereas
if lipid A-Kdo1 remains unphosphorylated, an additional
Kdo is added by the Kdo transferase (KdtA) and glycoform
B is assembled (Fig. 1) (10).
In previous studies with P. multocida strain VP161, we sys-
tematically inactivated each of the LPS transferase genes and
the Kdo kinase gene (kdkA) and analyzed the effects of these
mutations on the LPS structure and virulence in chickens (3,
10). In kdkA mutants, there is no phosphorylation of lipid
A-Kdo1, so all lipid A-Kdo1 acceptor molecules are used to
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produce full-length glycoform B (Fig. 1). These kdkA mutants
are fully virulent in chickens infected by the intramuscular
(i.m.) route (10). In contrast, P. multocida hptA mutants pro-
duce full-length glycoform B but lack the first heptosyltrans-
ferase (HptA) required for assembly of glycoform A beyond
lipid A-Kdo1-P (Fig. 1) (10). These hptA mutants are fully
attenuated in chickens due to the production of a large amount
of truncated LPS, rendering them vulnerable to host defense
mechanisms, such as antimicrobial peptides (10).
In the present study, we show that under in vivo selective
pressure, avirulent P. multocida hptA mutants can spontane-
ously revert to full virulence by way of secondary kdkA sup-
pressor mutations. These virulent isolates produce full-length
glycoform B LPS and no longer produce any truncated LPS.
Sequencing analysis of the mutated kdkA genes amplified from
each of the recovered in vivo hptA mutants demonstrated that
they all contained single nucleotide substitutions or deletions.
Importantly, four of the mutated kdkA genes were intact, but
each encoded a single amino acid substitution. Further analysis
confirmed that each amino acid substitution resulted in the loss
of Kdo kinase activity. This is the first report that defines the
amino acids essential for bacterial Kdo kinase activity, a critical
enzyme in LPS assembly.
MATERIALS AND METHODS
Bacterial strains, plasmids, media, and growth conditions. The bacterial
strains and plasmids used in this study are listed in Table 1. Escherichia coli was
grown routinely in Luria-Bertani broth. P. multocida strains were grown in brain
heart infusion (BHI) broth. Solid media were obtained by the addition of 1.5%
agar. When required, the media were supplemented with spectinomycin (100
g/ml), kanamycin (50 g/ml), or tetracycline (2.5 g/ml).
DNA manipulations. Restriction digests and ligations were performed accord-
ing to the manufacturers’ instructions using enzymes obtained from NEB (Ip-
swich, MA) or Roche Diagnostics (Mannheim, Germany). Plasmid DNA was
prepared using Qiagen plasmid minikits (Hamburg, Germany), while genomic
DNA was prepared using the cetyltrimethylammonium bromide (CTAB)
method (1). PCR amplification of DNA was performed using Taq DNA poly-
merase or an Expand high-fidelity PCR system (Roche Diagnostics) and purified
using a QIAquick PCR purification kit from Qiagen GmbH (Hamburg, Ger-
many). The oligonucleotides used in this study are listed in Table 1. Sequencing
reactions were performed using the Applied Biosystems Prism BigDye Termi-
nator mix, version 3.1. Electropherograms were generated on an Applied Bio-
systems 3730S genetic analyzer and were analyzed using the Vector NTI Ad-
vance, version 10, program (Invitrogen, Carlsbad, CA).
In trans complementation of the P. multocida kdkA mutant. We previously
constructed P. multocida kdkA mutant AL721 and showed that complementation
of this strain with the wild-type kdkA gene, encoded on plasmid pAL462, re-
stored expression of glycoform A LPS (10). For the complementation experi-
ments with the mutated kdkA genes, two independent plasmid constructs were
generated for each mutation, as follows. The kdkA gene was amplified directly
from each of the P. multocida hptA kdkA double mutants (Table 1), using
oligonucleotides BAP3914 and BAP3915. Each amplified product was then li-
gated into SalI- and BamHI-digested pAL99 (Table 1), such that transcription of
kdkA would be driven by the constitutive P. multocida tpiA promoter. The
nucleotide sequence of each of the recombinant plasmids was determined to
check the fidelity of the cloned gene and the tpi promoter region, and then each
plasmid was introduced into P. multocida kdkA mutant AL721, generating com-
plemented strains AL1799 through AL1806 (Table 1). As a control, the pAL99
vector was introduced separately into the kdkA mutant, generating strain AL839
(Table 1).
Structural analyses of LPS. LPS was isolated from plate-grown cells as de-
scribed previously (3, 10). Sugars were identified as their alditol acetate deriva-
tives and linkage analysis determined following methylation analysis by gas-liquid
chromatography–mass spectrometry (MS), as described previously (22). Capil-
FIG. 1. Schematic representation of LPS inner core assembly in the P. multocida wild-type (VP161), kdkA mutant (AL721), and hptA mutant
(AL836). Two LPS inner core structures, glycoforms A and B, are observed. The enzymes required for selected steps in the biosynthesis of each
glycoform are shown in boldface. Residues are heptose (Hep), 3-deoxy-D-manno-octulosonate (Kdo), and phosphate (P).
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lary electrophoresis (CE)-electrospray (ES)-MS analysis was performed as de-
scribed previously (22).
Assessment of virulence. Virulence trials with chickens were performed as
described previously (10). To check the phenotypes of the strains recovered from
infected chickens, muscle swab and blood samples were plated onto BHI agar
and BHI agar containing spectinomycin. The genotypes of the recovered strains
with respect to the hptA gene were assessed using two different PCR assays. To
identify the P. multocida hptA mutant, a primer located outside hptA (primer
BAP3327) was paired with a primer specific for the integrated plasmid located
within hptA (primer BAP2782). The amplification of a 700-bp product indicated
that the strain still contained an insertion within hptA. To identify P. multocida
wild-type revertant strains, primers flanking the hptA gene (primers BAP3966
and BAP3967) were used. P. multocida wild-type revertant strains were identified
by the PCR amplification of a 1,050-bp product, indicating the loss of the plasmid
insertion within hptA. To determine the LPS phenotype of the recovered strains,
proteinase K-treated whole-cell lysates of the bacteria recovered from each in
vivo site were separated by SDS-PAGE and visualized by carbohydrate silver
staining, as described previously (25).
Bioinformatic analysis. Amino acid sequence alignments were generated us-
ing COBALT, a constraint-based multiple-alignment tool that utilizes conserved
domain and local sequence similarity information (18).
Nucleotide sequence accession number. The GenBank accession number for
the nucleotide sequence of the P. multocida VP161 kdkA gene is HM448896.
RESULTS
P. multocida hptA mutants isolated from the blood of chick-
ens with fowl cholera express only full-length LPS. We previ-
ously observed that birds injected i.m. with 70 CFU of the P.
multocida hptA single-crossover insertion mutant AL836 dis-
played no signs of disease (10). To extend these data, a viru-
lence trial was conducted with chickens to determine the 50%
infectious dose of the hptA mutant. Three groups of seven
birds each were injected i.m. with 70, 7  103, or 7  105 CFU.
As expected (10), there were no signs of disease in the birds
injected with the lowest dose of the hptA mutant, but two birds
injected with 7  103 CFU and all birds injected with 7  105
CFU developed acute fowl cholera. As the hptA mutant was
known to be attenuated in chickens, we hypothesized that the
causative agent of disease was a wild-type revertant strain that
had lost the single-crossover insertion from within hptA. In-
deed, we have reported in a previous study that under in vivo
selective pressure, wild-type revertant strains can arise spon-
TABLE 1. Bacterial strains, plasmids, and primers used in this study
Strain, plasmid, or
primer Relevant description Source or reference
Strains
E. coli DH5 deoR endA1 gyrA96 hsdR17(rK
 mK
) recA1 relA1 supE44 thi-1 (lacZYA-
argFV169), 80dlacZM15 F
Bethesda Research
Laboratories
P. multocida
VP161 Serotype A:1, Vietnamese isolate from chickens 27
AL435 VP161 carrying a Tn916 insertion in gene pm1417, fully virulent 10
AL721 kdkA mutant of AL435, Specr 10
AL836 Nonpolar hptA mutant of AL435, Specr 10
AL839 AL721 containing pAL99, Specr Kanr 10
AL840, AL1808 AL721 containing pAL462, Specr Kanr 10
AL1774, AL1775 Spontaneous A112V kdkA mutants of AL836, Specr This study
AL1777, AL1778 Spontaneous R123P kdkA mutants of AL836, Specr This study
AL1780, AL1781 Spontaneous D193N kdkA mutants of AL836, Specr This study
AL1782, AL1783 Spontaneous H168Y kdkA mutants of AL836, Specr This study
AL1799 AL721 containing pAL856, Specr Kanr This study
AL1800 AL721 containing pAL857, Specr Kanr This study
AL1801 AL721 containing pAL858, Specr Kanr This study
AL1802 AL721 containing pAL860, Specr Kanr This study
AL1803 AL721 containing pAL861, Specr Kanr This study
AL1804 AL721 containing pAL862, Specr Kanr This study
AL1805 AL721 containing pAL863, Specr Kanr This study
AL1806 AL721 containing pAL864, Specr Kanr This study
Plasmids
pAL99 P. multocida expression plasmid (Kanr), constitutive tpiA promoter upstream of
cloning site
11
pAL462 Wild-type kdkA, cloned into pAL99 10
pAL856, pAL857 kdkA A112V, cloned into pAL99, independent clonings This study
pAL858, pAL860 kdkA R123P, cloned into pAL99, independent clonings This study
pAL861, pAL862 kdkA H168Y, cloned into pAL99, independent clonings This study
pAL863, pAL864 kdkA D193N, cloned into pAL99, independent clonings This study
Primers
BAP2782 GCCCTACACAAATTGGGAGA, pUA826-specific primer 10
BAP3327 GCACGCCTGCTGTGCTTTAG, reverse primer in kdkA gene This study
BAP3914 AAAGGGATCCGTGGCCATTCGCTATCTCTG, forward primer flanking kdkA
for expression, contains BamHI site
10
BAP3915 TATGTGTCGACCTTATGCTTGATATCCCGC, reverse primer flanking kdkA
for expression, contains SalI site
10
BAP3966 CACACAGGATCCATTGGACGAGATAATGATGCCG, forward primer flank-
ing hptA, contains BamHI site
10
BAP3967 ATAACAGTCGACGGTTCATCATTGAACGTC, reverse primer flanking hptA,
contains SalI site
10
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taneously within a population of P. multocida single-crossover
mutants and cause disease (3). Virulent, wild-type revertant
strains are no longer spectinomycin resistant, as they have lost
the single crossover insertion that encodes the spectinomycin
resistance gene aadA. Therefore, to determine the phenotype
of the P. multocida strain responsible for disease, blood and
muscle (from the site of injection) tissue samples were col-
lected at necropsy from six of the diseased birds and cultured
on BHI agar and BHI agar with spectinomycin. In all birds, the
P. multocida organism recovered from the site of injection was
able to grow on BHI agar with spectinomycin, indicating the
presence of the hptA mutant in the muscle tissue. Furthermore,
spectinomycin-resistant P. multocida was recovered from the
blood of four of the six diseased birds, suggesting that the hptA
mutant was able to cause systemic disease. To determine if
both mutant and wild-type revertant P. multocida isolates were
present in the samples, the bacteria on the nonselective plates
were patched onto selective (spectinomycin, 50 g/ml) and
nonselective plates (Table 2). Four of the six birds (birds 18,
21, 25, and 53) had the hptA mutant present in the blood and
at the intramuscular injection site. In addition, bird 18 also had
wild-type revertant P. multocida present at both sites. Al-
though there was evidence that the hptA mutant was present at
the injection site in birds 23 and 24, only wild-type revertant P.
multocida was detected in the blood and these bacteria were
not investigated further (Table 2). The spectinomycin-resistant
P. multocida isolates from the blood of four birds (birds 18, 21,
25, and 53) were chosen for further study.
The hptA region of the genome in six spectinomycin-resis-
tant isolates from each bird (three per site) was analyzed by
PCR. The results confirmed that the spectinomycin-resistant
P. multocida isolates recovered from the blood and muscle
tissue of birds 18, 21, 25, and 53 had retained pUA826 inte-
grated into the hptA gene (Table 2). We have previously shown
that the heptosyltransferase HptA is essential for addition of
heptose to the glycoform A inner core. P. multocida hptA
mutants are fully attenuated, as inactivation of hptA results in
a large amount of truncated glycoform A (lipid A-Kdo1-P)
present on the surface of these mutants (Fig. 1) (10). To
determine if the hptA mutants recovered from the infected
chickens still produced truncated LPS, we analyzed whole-cell
lysates from a number of the in vivo-derived hptA mutants by
SDS-PAGE and carbohydrate silver staining. The virulent
hptA mutants recovered from both the blood and muscle of the
infected birds no longer produced truncated LPS at detectable
levels (Fig. 2). This finding was confirmed by mass spectrom-
etry analysis of the LPS isolated from six P. multocida hptA
mutants derived from the blood of bird 18 and from two mu-
tants derived from the blood of bird 21, which clearly showed
the lack of glycoform A (Table 3). On the basis of previous
analysis of the assembly of the LPS inner core in P. multocida,
these data indicated that the in vivo-derived hptA mutants each
had a compensatory mutation which prevented the phospho-
rylation of the first Kdo residue by KdkA.
All virulent hptA mutants isolated from chickens have com-
pensatory mutations in the kdkA gene. Sequencing of the kdkA
gene from 12 independent in vivo-derived hptA mutants lack-
ing truncated glycoform A LPS revealed that 7 isolates con-
tained a point mutation within the kdkA open reading frame
which resulted in truncation of the KdkA protein (Table 4).
Interestingly, the remaining in vivo-derived P. multocida hptA
mutants expressed a complete kdkA gene with a single point
mutation, resulting in one of the following amino acid substi-
tutions: A112V, R123P, D193N, or H168Y (Table 4). These
data indicate that all these amino acid substitutions result in
the loss of KdkA kinase activity.
Complementation of a defined P. multocida kdkA mutant
with the R123P, H168Y, or D193N kdkA fails to restore pro-
duction of glycoform A. To determine if the KdkA transferases
TABLE 2. Analysis of in vivo-derived P. multocida isolatesa
Bird Time ofdeath (h)b
Muscle Blood
% Specrc No. positive for pUA826::hptA/total no. testedd % Spec
r No. positive for pUA826::
hptA/total no. testedd
18 28 50 3/3 40 10/10
21 37 100 3/3 100 5/5
25 27 100 3/3 100 3/3
53 48 100 3/3 100 3/3
23 37 10 NDe 0 ND
24 33 20 ND 0 ND
a Spectinomycin-resistant colonies isolated from each tissue site were analyzed by PCR for the presence of pUA826 integrated into the hptA gene.
b All birds showing terminal signs of fowl cholera were euthanized, in accordance with animal ethics requirements.
c Percentage of spectinomycin-resistant P. multocida isolates in tissue sample.
d Number of spectinomycin-resistant colonies positive by PCR for pUA826 integrated into hptA gene.
e ND, not done.
FIG. 2. Analysis of P. multocida LPS produced by in vivo-derived
hptA mutants by PAGE and carbohydrate silver staining of whole-cell
lysates. Truncated LPS is indicated by the arrow. WT, wild-type strain
(VP161); H, in vitro-grown hptA mutant (AL836); B, blood isolate; M,
muscle isolate. The positions of the relevant standard molecular mass
markers (kDa) are shown on the right.
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containing the amino acid changes were functional, expression
plasmids containing KdkA with one of the amino acid substi-
tutions indicated above were constructed in duplicate. These
plasmids, along with a plasmid containing wild-type kdkA
(pAL462), were then introduced separately into the P. multo-
cida kdkA mutant, AL721, which can no longer phosphorylate
the first Kdo residue and which is therefore unable to produce
glycoform A LPS (Fig. 1) (10). CE-ES-MS analyses of isolated
LPS showed that wild-type levels of both glycoform A and B
LPS were produced when the kdkA mutant was complemented
in trans with the wild-type kdkA gene (Table 3). However,
complementation in trans with a kdkA gene encoding an
R123P, H168Y, or D193N amino acid substitution failed to
restore the expression of glycoform A LPS, confirming that
TABLE 3. Negative ion CE-ES-MS data and proposed compositions of O-deacylated LPS (LPS-OH) from the P. multocida parent (AL435),
the hptA mutant (AL836), in vivo-derived kdkA and hptA double mutants, the kdkA mutant (AL721), and complemented kdkA mutant strains
Description, strain
Observed ions (m/z) Molecular mass (Da)a Relative
intensity Proposed composition(M-2H)2 (M-3H)3 Observed Calculated
Parent, AL435 1,488.6 991.9 2,978.9 2,977.6 0.1 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
1,499.4 999.2 3,000.7 2,999.5 0.1 2PCho, 4Hex, 4Hep, Kdo-P, lipid A-OH
1,548.9 1,032.9 3,100.7 3,100.6 0.2 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
1,560.0 1,040.1 3,122.6 3,122.6 0.6 2PCho, 4Hex, 4Hep, Kdo-P-PEtn, lipid A-OH
1,621.5 1,081.2 3,245.8 3,245.6 1.0 2PCho, 4Hex, 4Hep, Kdo-P-PEtn, lipid A-OH-PEtn
hptA mutant, AL836 616.8 1,235.6 1,252.2 0.1 Kdo-P, lipid A-OH
678.4 451.6 1,358.8 1,375.2 0.2 Kdo-P-PEtn, lipid A-OH
739.8 492.6 1,481.2 1,498.3 0.4 Kdo-P-PEtn, lipid A-OH-PEtn
1,487.4 992.1 2,978.1 2,977.6 0.3 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
1,549.9 1,033.4 3,102.6 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
In vivo-derived kdkA hptA
double mutants
A112V KdkA, AL1774 1,487.4 992.1 2,978.1 2,977.6 0.3 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
(AL1775),b bird 18 1,548.9 1,032.9 3,100.7 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
R123P KdkA, AL1777 1,487.7 992.1 2,978.3 2,977.6 0.4 (0.3)c 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
(AL1778), bird 18 1,549.5 1,032.6 3,100.9 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
D193N KdkA, AL1780 1,487.7 991.5 2,977.5 2,977.6 0.4 (0.5) 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
(AL1781), bird 18 1,549.2 1,032.3 3,100.1 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
H168Y KdkA, AL1782 1,487.7 991.5 2,977.5 2,977.6 0.4 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
(AL1783), bird 21 1,549.2 1,032.3 3,100.1 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
KdkA complementation data
kdkA mutant, AL721 992.1 2,979.3 2,977.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
1,032.9 3,101.7 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
kdkA mutant  vector, 1,487.7 991.5 2,977.5 2,977.6 0.4 (0.3) 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
AL839 (AL1807) 1,548.9 1,032.9 3,100.7 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
kdkA mutant  wild-type 991.8 2,978.4 2,977.6 0.1 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
KdkA, AL840 (AL1808) 1,032.9 3,101.7 3,100.6 0.3 (0.2) 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
1,560.0 1,040.1 3,122.6 3,122.6 0.6 (0.5) 2PCho, 4Hex, 4Hep, Kdo-P-PEtn, lipid A-OH
1,621.5 1,081.2 3,245.8 3,245.6 1.0 2PCho, 4Hex, 4Hep, Kdo-P-PEtn, lipid A-OH-PEtn
kdkA mutant  A112V 1,488.0 991.5 2,977.7 2,977.6 0.6 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
KdkA, AL1799 (AL1800) 1,549.2 1,032.6 3,100.6 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
1,040.1 3,123.3 3,122.6 0.3 (0.2) 2PCho, 4Hex, 4Hep, Kdo-P-PEtn, lipid A-OH
1,621.5 1,080.9 3,245.4 3,245.6 0.4 (0.5) 2PCho, 4Hex, 4Hep, Kdo-P-PEtn, lipid A-OH-PEtn
kdkA mutantR123P 1,488.0 991.5 2,977.7 2,977.6 0.3 (0.4) 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
KdkA, AL1801 (AL1802) 1,548.9 1,032.6 3,100.4 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
kdkA mutant  H168Y 1,487.7 991.5 2,977.5 2,977.6 0.4 (0.5) 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
KdkA, AL1803 (AL1804) 1,549.2 1,032.6 3,100.6 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
kdkA mutant  D193N 1,487.7 991.2 2,977.0 2,977.6 0.4 (0.3) 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH
KdkA, AL1805 (AL1806) 1,548.9 1,032.6 3,100.4 3,100.6 1.0 2PCho, 3Hex, 4Hep, 2Kdo, lipid A-OH-PEtn
a Molecular mass was determined from the observed ions or calculated from the proposed composition. Average mass units were used for calculation of molecular
weight, based on the proposed composition, as follows: lipid A-OH, 952.00; hexose (Hex), 162.15; heptose (Hep), 192.17; Kdo-P, 300.13; Kdo, 220.18; PEtn, 123.05;
phosphocholine (PCho), 165.05.
b Duplicate strains were analyzed, but data for only one strain are shown.
c Where the relative intensity of each glycoform differed between duplicate strains, the value for the second strain is shown in parentheses.
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amino acids R123, H168, and D193 in KdkA are essential for
kinase function (Table 3). Although LPS structural analysis
showed that the A112V kdkA mutants AL1774 and AL1775
did not express observable amounts of the glycoform A inner
core, complementation experiments showed that providing this
gene in trans on the high-copy-number expression plasmid
pAL99 allowed some expression of glycoform A LPS (Table 3,
AL1799 and AL1800). However, the relative intensity values
obtained from the CE-ES-MS data suggest that the amount of
glycoform A produced by these strains was significantly less
than the amount of glycoform A expressed when wild-type
KdkA was provided in trans (approximately 30% and 82% of
total LPS, respectively) (Table 3).
P. multocida KdkA is a member of the protein kinase super-
family. Previous bioinformatic analyses indicated that bac-
terial LPS kinases are homologs of eukaryotic protein ki-
nases, a large group of regulatory enzymes that are bilobal
in structure, consisting of a small N-terminal subdomain and
a large C-terminal subdomain separated by a linker or hinge
region (18). The amino acids essential for function in the
eukaryotic proteins of this superfamily are also highly con-
served across the bacterial LPS kinases (15). Using the
COBALT multiple-alignment tool (18), we compared the
amino acid sequence of P. multocida KdkA with the amino
acid sequences of Kdo kinases from a number of different
bacterial species and the amino acid sequence of the cata-
lytic subunit of the eukaryotic protein kinase A (cPKA)
(Fig. 3). This alignment showed that 23 amino acids were
conserved among all of the aligned kinases and revealed that
three of the four substitutions (R123P, H168Y, and D193N)
identified in the P. multocida kdkA mutants were in regions
of the protein that aligned with critical residues within
cPKA. The nonconservative substitution R123P (in the po-
sition equivalent to N115 in cPKA) is predicted to be posi-
tioned at the start of the 5th beta sheet immediately pre-
ceding the linker region (12). The relatively conservative
H168Y substitution (in the position equivalent to Y164 in
cPKA) is positioned in the predicted catalytic loop of the
kinase where phosphate transfer from the ATP donor to the
acceptor molecule occurs (Fig. 3). The D193N substitution
in P. multocida KdkA aligns within the region predicted to
form the Mg2 positioning loop and is situated only 2 amino
acids downstream from the essential D184 in cPKA. Inter-
estingly, the fourth mutation, A112V, which resulted in a
significant reduction in kinase activity (Table 3), does not
appear to be located in a critical region of the kinase. More-
over, the equivalent residue that aligns with A112 in both
cPKA and the Haemophilus ducreyi KdkA is also valine.
DISCUSSION
P. multocida simultaneously produces LPS with two different
inner core structures, termed glycoforms A and B. Glycoform
A has a single phosphorylated Kdo residue attached to the
lipid A (lipid A-Kdo1-P), whereas the glycoform B structure
contains two unphosphorylated Kdo residues (lipid A-Kdo1-
Kdo2) (10). In Gram-negative bacteria, glycoform B is the most
commonly occurring LPS core structure, whereas glycoform A
is produced by relatively few bacterial species, including Hae-
mophilus influenzae, Vibrio cholerae, and the veterinary patho-
gens Mannheimia haemolytica and Actinobacillus pleuropneu-
moniae. The production of both the glycoform A and
glycoform B inner core structures simultaneously has been
detected only in P. multocida and M. haemolytica, both of
which belong to the Pasteurellaceae family (16, 23). H. influen-
zae, which is also a member of the Pasteurellaceae family, can
synthesize only a glycoform A inner core, as the H. influenzae
Kdo transferase is monofunctional and therefore unable to add
a second Kdo residue (26).
The kinase required for the phosphorylation of the first
Kdo residue in P. multocida glycoform A is Kdo kinase
(KdkA). Following Kdo phosphorylation, the first heptose
residue is added by the glycoform A-specific heptosyltrans-
ferase, HptA (10). In a previous study, we showed that P.
multocida hptA mutant AL836 produced full-length glyco-
form B LPS but was rendered avirulent by the large amount
of truncated glycoform A LPS present on its surface. In
contrast, P. multocida kdkA mutant AL721 was fully viru-
lent; this mutant produced full-length glycoform B but did
not express any truncated glycoform A, as it was unable to
phosphorylate the first Kdo residue (10). In the present
study, we found that introduction of the hptA mutant into
chickens at high doses resulted in the natural selection and
growth of spontaneous kdkA hptA double mutants that no
longer assembled any truncated glycoform A.
Homologs of P. multocida KdkA are present in most species
within the Pasteurellaceae family, including members of the
genera Pasteurella, Haemophilus, Actinobacillus, and Mannhe-
imia. Outside of the Pasteurellaceae family, KdkA homologs
are also expressed by the human gastrointestinal pathogens V.
cholerae and Vibrio parahaemolyticus, as well as by a number of
species within the order Alteromonadales.
Previous bioinformatic analyses of the P. multocida Kdo
kinase showed that KdkA is distantly related to eukaryotic
protein kinases, of which cPKA is the best characterized (13–
15, 24). In eukaryotic species, cPKA is required to catalyze the
transfer of phosphate from MgATP to the target protein sub-
strate. The structure of cPKA has been determined and con-
sists of two lobes, one small and one large, with the catalytic
site or ATP binding pocket being located in the active cleft
between the two lobes (13–14). Most of the highly conserved
amino acids identified in the cPKA structure are located in the
TABLE 4. Nucleotide changes observed in the kdkA gene amplified
from in vivo-derived P. multocida hptA kdkA double mutants
Bird Sample Nucleotidechange Result Strain designations
18 Muscle T78 deleted Frame shift
after F26
18 Blood C64T Stop
18 Blood C335T A112V AL1774, AL1775
18 Blood G368C R123P AL1777, AL1778
18 Blood C424T Stop
18 Blood G577A D193N AL1780, AL1781
21 Muscle C502T H168Y
21 Blood C502T H168Y AL1782, AL1783
25 Muscle C478T Stop
25 Blood C538T Stop
53 Muscle C466T Stop
53 Blood C466T Stop
3674 HARPER ET AL. INFECT. IMMUN.
 o
n
 O
ctober 18, 2015 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
active cleft and are required for MgATP binding and catalysis
(14). In this study we identified P. multocida mutants that
encode a nonfunctional KdkA with an H168Y substitution. In
cPKA, the amino acid in the equivalent position (position 164)
is also tyrosine, which is located within the active cleft and
close to the catalytic aspartate 166 (Fig. 3). The active site in
cPKA is dependent upon a number of hydrogen bond networks
for correct conformation. To achieve this conformation, the
amino acid in position 164 of cPKA needs to be an efficient
hydrogen-bonding amino acid, such as tyrosine or histidine (14,
19). There is no structure available for any bacterial Kdo ki-
nase, but it is likely that the fully conserved histidine at position
168 of the P. multocida KdkA kinase is also important for the
function of the active cleft. Although the hydrogen-bonding
capability of the amino acid in this position has probably been
conserved, the total lack of kinase activity by H168Y KdkA
suggests that the substitution to tyrosine results in destabiliza-
tion of the catalytic loop or other conformational changes that
disrupt function.
The Kdo kinase expressed by P. multocida spontaneous
mutants AL1777 and AL1778 had the amino acid substitu-
tion R123P. The amino acid at the equivalent position (po-
sition 115) in cPKA is asparagine (Fig. 3), which is located
at the start of the highly conserved 5th beta strand, which
immediately precedes the linker region (cPKA amino acids
120 to 127) (19). This region is important for the correct
interlobe movement, allowing both an open form, for ATP
to access the catalytic site, and a closed form, so that key
FIG. 3. Amino acid sequence alignment of the catalytic subunit of cyclic AMP-dependent protein kinase (cPKA) from Mus musculus (GenBank
accession no. AAA39936.1) aligned with the KdkA proteins from Mannheimia succiniciproducens (GenBank accession no. Q65R39.2), Actinoba-
cillus pleuropneumoniae (GenBank accession no. YP_001651918.1), Haemophilus influenzae (GenBank accession no. NB_438429.1), Haemophilus
ducreyi (GenBank accession no. NB_873578.1), and Pasteurella multocida strain VP161 (GenBank accession no. HM448896). Numbers above the
alignment refer to the amino acid positions relative to the cPKA sequence. Conserved amino acids are shown in boldface and are highlighted in
gray. Highly conserved amino acids within the kinase superfamily are red and are shown in boldface, and critical regions of the kinase are marked
with a solid line. The known secondary structure of the cPKA subunit is shown in red above the alignment; , alpha helical, 	, beta sheet. The
positions of amino acid substitutions A112V, R123P, H168Y, and D193N in P. multocida KdkA are indicated with arrowheads, and the
substitutions are shown underneath the P. multocida VP161 sequence.
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amino acids are brought into the correct conformation for
ATP alignment and subsequent catalysis (12). Thus, the
nonconservative R123P substitution in KdkA is likely to
have a significant impact on the secondary structure of this
kinase, and it is probable that the mutation affects the hinge
action of the linker region.
The Kdo kinase expressed by AL1780 and AL1781 con-
tained a D193N substitution that led to the complete loss of
kinase activity. Analysis of the alignment with cPKA in this
region showed that there are two aspartate residues in close
proximity to each other in all the bacterial KdkA kinases ex-
amined. In the COBALT alignment, D191 aligns directly with
the cPKA essential catalytic site amino acid D184, and the
KdkA D193, present in all KdkA proteins examined, aligns 2
amino acids downstream. In cPKA, D184 is required to chelate
the activating Mg2 ion, which in turn binds to the 	- and

-phosphates of ATP (28). In the present study, we showed
that the D193N substitution leads to a complete loss of KdkA
kinase activity. This D193 residue may be critical for kinase
function because of its close proximity to the predicted cata-
lytic site amino acid D191, or alternatively, D193 rather than
D191 may be the essential catalytic site amino acid in bacterial
Kdo kinases.
The Kdo kinase mutants AL1774 and AL1775 expressed no
glycoform A LPS as a result of an A112V substitution within
KdkA. However, when this mutant kdkA gene was expressed
from a high-copy-number expression plasmid, a low level of
KdkA activity was observed. On the basis of the COBALT
alignment of the bacterial Kdo kinases with the eukaryotic
cPKA, the A112V substitution was not in a highly conserved or
structurally critical region of the protein, and valine is also in
the equivalent position in both cPKA and the H. ducreyi KdkA.
Nevertheless, it is clear that in P. multocida KdkA, A112 is
required for full enzyme activity.
In conclusion, the use of a fowl cholera natural host in-
fection model has allowed us the unique opportunity to
rapidly identify essential amino acids in the P. multocida
Kdo kinase, KdkA, required for the addition of phosphate
to the Kdo1 of glycoform A LPS. Four of the kdkA mutants
identified in this study encoded complete kdkA genes, but
each had a single nucleotide change leading to an amino
acid substitution. On the basis of analysis of the LPS pro-
duced by the kdkA mutants, we have shown that these
changes in the KdkA protein either abolish (R123P, H168Y,
and D193N) or result in the significant loss (A112V) of
kinase activity on the lipid A-Kdo1 acceptor molecule. Fur-
thermore, on the basis of comparisons with the eukaryotic
protein kinases, three of the mutations that abolish kinase
activity are predicted to be in or near two important regions
of the kinase molecule, namely, the linker region hinging the
two lobes of the kinase molecule and the active cleft con-
taining the ATP binding pocket. This is the first report of
the identification of residues critical for the function of the
bacterial Kdo kinase KdkA and will form a solid basis for
future structural studies and the identification of inhibitors
for this important LPS kinase.
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